"ONCOMINE ACUTE MYELOID LEUKAEMIA (AML) PANEL
Acute myeloid leukemia (AML) is a neoplastic disease of the hematopoietic stem cell defined by impaired differentiation capacity, clonal expansion and accumulation of immature cells with suppression of polyclonal residual hematopoiesis. The resulting peripheral cytopenias accounts for the most frequent clinical symptoms at diagnosis (fatigue, dyspnea,fever and infections, hemorrhage). The sequencing of genes related to pathophysiology of AML helps in making diagnosis, and also for prognostication and therapeutic decision making.
Parameter(s) covered : 1
Report Frequency: Sample by 1st / 16th of every month; Report 15th / 30th of Same month
Special Instruction: Duly filled Nx Gen Sequencing (NGS) Test Requisition Form (Form 40) is mandatory.
Price : ₹ 37800.00
Parameters
- ONCOMINE ACUTE MYELOID LEUKAEMIA (AML) PANEL